Drug Type TCR-T Cell therapy |
Synonyms HBV Chronic Infection (Theravectys) |
Target |
Action inhibitors |
Mechanism HBsAg inhibitors(HBsAg inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B, Chronic | Phase 2 | France | - | |
| Liver Cancer | Preclinical | - | 06 Jan 2026 |





